As per MRFR analysis, the India Rapid Diagnostics Market Size was estimated at 1.73 (USD Billion) in 2023.The India Rapid Diagnostics Market Industry is expected to grow from 2.51(USD Billion) in 2024 to 5.96 (USD Billion) by 2035. The India Rapid Diagnostics Market CAGR (growth rate) is expected to be around 8.174% during the forecast period (2025 - 2035).
Key India Rapid Diagnostics Market Trends Highlighted
The India Rapid Diagnostics Market is significantly expanding on account of the growing requirement for point-of-care testing services across several healthcare facilities. There is also a growing adoption of rapid diagnostic tests across hospitals, clinics, and patients’ homes due to the increasing prevalence of infectious diseases along with the need for effective and efficient diagnostics. In addition, the development and funding of basic healthcare services and facilities by the government is an important driver of the market. The National Health Mission and other government efforts for better control and prevention of diseases are promoting the use of rapid diagnostic tools for public health issues in India.
The Indian market presents a lot of opportunities because the case of increased technological innovation and better awareness among the healthcare professionals and general public inspires new diagnostic products. Increased health awareness after the pandemic has led to the adoption and reliance on rapid diagnostics and innovative solutions. This aids local manufacturers and startups ready to meet the needs of the people, even those in rural areas where orthodox hospitals and laboratories face a lot of challenges. These days, there is a clear movement toward telehealth services that combine rapid diagnostic tests with virtual consultations, where patients can quickly have their test results and medical attention facilitated.
Moreover, the recent tendency towards the integration of the services provided by the public and private sectors enables better and faster diagnosis to be done all over the country. As the enacting of the laws relating diagnostic tools changes, there is likely to be an increasing scope of for collaboration and investments which will further propel the rapid diagnostics industry in India.
India Rapid Diagnostics Market Drivers
Rising Prevalence of Infectious Diseases
The increasing burden of infectious diseases in India serves as a significant driver for the India Rapid Diagnostics Market Industry. For instance, the National Health Mission reported a rise in the cases of tuberculosis, with approximately 2.64 million registered cases in India in 2020, indicating a critical demand for rapid diagnostic solutions. This alarming trend showcases a need for efficient testing mechanisms to control outbreaks and improve patient outcomes.The ability to diagnose and treat infectious diseases promptly is crucial for public health management, thereby propelling the growth of rapid diagnostics. Furthermore, the review from the Indian Council of Medical Research (ICMR) suggests that over 1.5 million people in India are diagnosed with malaria each year, reinforcing the urgent requirement for rapid testing solutions in rural and urban healthcare systems.
Government Initiatives for Healthcare Improvement
The Indian government has implemented various initiatives aimed at improving healthcare infrastructure which enhances the prospects for the India Rapid Diagnostics Market Industry. Programs like Ayushman Bharat, which aims to provide health insurance to over 500 million people, significantly increase healthcare accessibility. The allocation of approximately USD 13 billion in the 2020-2021 budget towards health has catalyzed investments in diagnostics, particularly in rural areas where access to diagnostic facilities is limited.Such initiatives not only create a conducive environment for rapid diagnostics but also facilitate partnerships with established organizations like the WHO and various tech companies to introduce innovative testing solutions, ultimately boosting market growth.
Technological Advancements in Diagnostic Tools
Innovations in technology have significantly impacted the rapid diagnostics landscape in India, acting as a robust growth driver for the India Rapid Diagnostics Market Industry. The development of point-of-care testing (POCT) devices, which provide immediate results, has gained momentum. According to industry reports, the market for POCT is expected to grow at a rate of 15-20% annually due, in part, to advancements made by companies such as Mylab Discovery Solutions, a prominent Indian player known for its rapid RT-PCR testing kits during the COVID-19 pandemic.The push towards technological integration in healthcare challenges traditional diagnostics, offering quicker, more accessible testing options critical for timely disease management across India. This creates opportunities for expansion within the market, leveraging both public and private sector investment.
India Rapid Diagnostics Market Segment Insights
Rapid Diagnostics Market Application Insights
The India Rapid Diagnostics Market is rapidly evolving, particularly within the Application segment, which plays a pivotal role in ensuring accessible healthcare solutions across the nation. This segment encompasses a variety of crucial analytical methods, including Blood Glucose Testing, Infectious Disease Testing, Cardiometabolic Testing, Pregnancy Fertility Testing, Fecal Occult Blood Testing, Coagulation Testing, and Toxicology Testing.
Each of these applications serves distinct yet significant needs in the healthcare landscape. Blood Glucose Testing has become essential for the management of diabetes, catering to a growing diabetic population in India. With an increasing number of people being diagnosed with this chronic illness, the demand for accurate and quick monitoring solutions continues to rise, promoting better health management practices.Infectious Disease Testing is also gaining traction, especially in the context of public health initiatives aimed at combating prevalent diseases such as tuberculosis, malaria, and HIV.
The ability to swiftly identify infections supports timely intervention and treatment, crucial for containing outbreaks and improving overall community health metrics. Similarly, Cardiometabolic Testing plays a vital role in assessing cardiovascular and metabolic health, which is critical in a country experiencing a rise in lifestyle-related diseases due to urbanization and changing diets.Pregnancy Fertility Testing remains a focal application, with many couples seeking timely answers for family planning and reproductive health.
This application not only highlights the importance of early detection but also significant advancements in testing technologies that facilitate patient convenience. On the other hand, Fecal Occult Blood Testing provides screenings for colorectal cancer, an essential part of preventive healthcare strategies, especially given India's growing emphasis on early cancer detection.Coagulation Testing, crucial for diagnosing bleeding disorders and monitoring patients on anticoagulants, addresses an integral healthcare aspect, ensuring safe treatment protocols for individuals with specific medical needs. Lastly, Toxicology Testing assists in the identification of substance abuse and exposure to harmful chemicals, playing an essential role in public safety and health regulation.
The India Rapid Diagnostics Market is characterized by the flexibility and adaptability of these applications, which integrate new technologies to meet the changing dynamics of healthcare needs in India, capturing not only the attention of healthcare professionals but increasingly, patients themselves who are seeking self-monitoring solutions. The rising prevalence of various health issues, coupled with the urban population's growing demand for accessible and efficient diagnostic systems, positions the Application segment as a vital component supporting the overall growth and expansion of India's healthcare landscape. The strategic prioritization of rapid and reliable diagnostic applications is crucial to driving significant health outcomes and advancing India's healthcare quality.
Rapid Diagnostics Market Product Type Insights
The India Rapid Diagnostics Market is characterized by a diverse range of product types, with Over the Counter (OTC) Kits and Professional Kits emerging as key segments. OTC Kits, commonly accessible to consumers without the need for a prescription, enable rapid testing for various conditions, enhancing self-diagnosis and health management. This segment has seen notable demand due to the increasing awareness of health issues and the emphasis on preventative care among the Indian population. Meanwhile, Professional Kits cater to healthcare providers, offering reliable solutions for accurate diagnosis in clinical settings.These kits play a critical role in streamlining patient management and improving healthcare outcomes. The growth of both segments is fueled by rising healthcare expenditure, increased prevalence of infectious diseases, and advancements in technology, alongside the growing trend of digital health solutions in India. The adaptability and convenience of OTC Kits combined with the trusted efficacy of Professional Kits position both segments favorably within the market, reflecting robust potential in enhancing diagnostic accessibility across various demographics in the country.The expanding healthcare infrastructure and supportive government initiatives further bolster the prospects for growth in the India Rapid Diagnostics Market.
India Rapid Diagnostics Market Key Players and Competitive Insights
The India Rapid Diagnostics Market is witnessing significant growth, driven by an increased prevalence of infectious diseases and a rising demand for quick and accurate diagnostic solutions. The competitive landscape in this market is characterized by both global players and regional companies that are striving to innovate and offer a diverse range of products. The market is influenced by various factors including technological advancements, changing healthcare policies, and an expanding healthcare infrastructure that emphasizes the importance of rapid testing. As the healthcare sector continues to evolve, companies are focusing on strategic partnerships, collaborations, and advancements in diagnostics technology to enhance their market presence and meet the growing needs of healthcare providers and patients.Medtronic has established a notable presence in the India Rapid Diagnostics Market by capitalizing on its strengths in medical technology and innovation. The company’s commitment to providing high-quality diagnostics solutions has enabled it to cater effectively to the evolving healthcare demands in India.
Medtronic's strong focus on research and development has led to the introduction of state-of-the-art products tailored for the Indian population, addressing specific health challenges. Moreover, its efficient distribution network enhances its ability to deliver timely diagnostic solutions across various regions of India, thereby solidifying its position as a key player in the market. The company also engages in educational initiatives and training for healthcare professionals, further strengthening its reputation and influence in the rapid diagnostics space.Abbott plays a crucial role in the India Rapid Diagnostics Market, known for its broad portfolio of innovative diagnostic products and services.
The company's key offerings include rapid tests for infectious diseases, molecular diagnostics, and point-of-care testing solutions, which cater to the diverse needs of Indian healthcare providers. Abbott's robust market presence is underpinned by a strong distribution network that ensures accessibility to its products across urban and rural areas. The company has consistently focused on strategic partnerships and collaborations with local healthcare institutions, allowing them to enhance their market reach.
Furthermore, Abbott has made notable investments in research and development specific to the Indian market, enabling them to introduce products that align with local health conditions. With a commitment to excellence and quality, Abbott continues to strengthen its position within the India Rapid Diagnostics Market.
Key Companies in the India Rapid Diagnostics Market Include:
India Rapid Diagnostics Market Industry Developments
The India Rapid Diagnostics Market is witnessing significant developments, particularly in the context of emerging health technologies and increasing demand due to the ongoing focus on healthcare. In October 2023, Medtronic announced a new product launch aimed at enhancing rapid diagnostic capabilities, indicating a growth trajectory in this sector. Abbott's advancements in molecular diagnostics have been pivotal, particularly with their rapid testing solutions garnering attention for infectious diseases. In recent times, Dr. Lal PathLabs and Mylab Discovery Solutions have also expanded their portfolios to include innovative rapid testing methodologies.
Notably, Siemens Healthineers and Thermo Fisher Scientific are continuously investing in RD to bolster their market presence. Noteworthy mergers include Alere's acquisition by Abbott, which has strengthened Abbott's position in the rapid diagnostics arena. The overall market is projected to grow significantly, driven by increased government initiatives and funding in the healthcare sector, particularly following the pandemic.
In the last two years, the demand for rapid testing solutions has surged, underscoring the importance of timely diagnostics in India's healthcare landscape. This evolution, backed by various stakeholders, is essential for addressing public health challenges effectively.
India Rapid Diagnostics Market Segmentation Insights
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2023 | 1.73(USD Billion) |
| MARKET SIZE 2024 | 2.51(USD Billion) |
| MARKET SIZE 2035 | 5.96(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.174% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | Medtronic, Abbott, Dr. Lal PathLabs, Mylab Discovery Solutions, Hewlett Packard Enterprise, Arkray, ZyBio, Alere, Thermo Fisher Scientific, Roche, Siemens Healthineers, Srinivasa Diagnostics, BioRad Laboratories, Panbio, BD |
| SEGMENTS COVERED | Application, Product Type |
| KEY MARKET OPPORTUNITIES | Increased prevalence of infectious diseases, Growing demand for point-of-care testing, Rising focus on preventive healthcare, Technological advancements in diagnostics, Expansion of telemedicine services |
| KEY MARKET DYNAMICS | Increasing prevalence of diseases, Growing demand for rapid testing, Advancements in diagnostic technology, Rising healthcare expenditure, Expansion of healthcare infrastructure |
| COUNTRIES COVERED | India |
Frequently Asked Questions (FAQ) :
The India Rapid Diagnostics Market is expected to be valued at 2.51 billion USD in 2024.
By 2035, the market is expected to grow to 5.96 billion USD.
The anticipated compound annual growth rate (CAGR) is 8.174 percent for the period from 2025 to 2035.
The Blood Glucose Testing segment is expected to dominate the market, valued at 0.644 billion USD in 2024.
The Infectious Disease Testing segment is projected to reach approximately 1.344 billion USD by 2035.
Major players include Medtronic, Abbott, Dr. Lal PathLabs, Mylab Discovery Solutions, and Roche among others.
The Cardiometabolic Testing application is valued at 0.465 billion USD in 2024.
The Pregnancy & Fertility Testing segment is expected to reach 0.865 billion USD by 2035.
Fecal Occult Blood Testing is projected to have a market value of 0.4 billion USD in 2024.
Key growth drivers include increasing health awareness, technological advancements, and a rise in infectious diseases.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
